Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

InspireMD, Inc. Director's Dealing 2025

Aug 1, 2025

34187_dirs_2025-08-01_25523148-8394-4e51-8f9d-89dacfcdaad9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2025-07-30

Reporting Person: ROUBIN GARY S (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-07-30 Common Stock P 41322 $2.42 Acquired 608425 Direct

Footnotes

F1: The shares of common stock reported in this row represent shares of restricted stock that were acquired in a private placement transaction on July 30, 2025 pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Private Placement").

F2: The purchase price per share of common stock in the Private Placement was $2.42.